These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7222728)

  • 1. Pindolol: disposition and metabolism in rhesus monkeys after chronic treatment.
    Maurer G; Donatsch P; Galliker H; Kiechel JR; Meier J
    Xenobiotica; 1981 Jan; 11(1):33-41. PubMed ID: 7222728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of pindolol in patients with renal failure.
    Ohnhaus EE; Heidemann H; Meier J; Maurer G
    Eur J Clin Pharmacol; 1982; 22(5):423-8. PubMed ID: 7117354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of pindolol in humans and several animal species.
    Schwarz HJ
    Am Heart J; 1982 Aug; 104(2 Pt 2):357-64. PubMed ID: 7102525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous tubular excretion and reabsorption of pindolol in man.
    Balant L; Muir K; Dayer P; Gorgia A; Eberlin JL; Estreicher J; Fabre J
    Eur J Clin Pharmacol; 1981; 21(1):65-72. PubMed ID: 7333348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of unchanged pindolol in patients with impaired renal function.
    Ohnhaus EE
    Br J Pharmacol; 1973 Mar; 47(3):620P-621P. PubMed ID: 4730841
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.
    Krause W; Kühne G
    Drug Metab Dispos; 1983; 11(2):91-6. PubMed ID: 6133729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a new beta-adrenoceptor blocking agent, LF 17-895, in man.
    Gugler R; Kreis L; Dengler HJ
    Arzneimittelforschung; 1975 Jul; 25(7):1067-72. PubMed ID: 241357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.
    Gross AS; McLachlan AJ; Minns I; Beal JB; Tett SE
    Br J Clin Pharmacol; 2001 Jun; 51(6):547-55. PubMed ID: 11422014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single and multiple dose pharmacokinetics of pindolol.
    Gugler R; Bodem G
    Eur J Clin Pharmacol; 1978 Mar; 13(1):13-6. PubMed ID: 639828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE; Krieter PA
    Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.
    Humpel M; Toda T; Oshino N; Pommerenke G
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):207-19. PubMed ID: 7308240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
    Meier J
    Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of pindolol in liver disease.
    Ohnhaus EE; Münch U; Meier J
    Eur J Clin Pharmacol; 1982; 22(3):247-51. PubMed ID: 7106158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of moxestrol in animals--rat, dog and monkey.
    Salmon J; Coussediere D; Cousty C; Raynaud JP
    J Steroid Biochem; 1983 Aug; 19(2):1223-34. PubMed ID: 6887930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic disposition of guanabenz in the rhesus monkey.
    Meacham RH; Chiang ST; Kick CJ; Sisenwine SF; Jusko WJ; Ruelius HW
    Drug Metab Dispos; 1981; 9(6):509-14. PubMed ID: 6120807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of parenteral dezocine in rhesus monkeys and dogs.
    Sisenwine SF; Tio CO; Liu AL; Ruelius HW
    Drug Metab Dispos; 1982; 10(4):366-70. PubMed ID: 6126336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.